[go: up one dir, main page]

LV10292A - Olbaltumvielas DNS vektori farmaceitiskas kompozicijas olbaltumvielu pielietojums kompozicija uzturam farmaceitiskas kompozicijas iegusanas panemiens bernu uztura iegusanas panemiens - Google Patents

Olbaltumvielas DNS vektori farmaceitiskas kompozicijas olbaltumvielu pielietojums kompozicija uzturam farmaceitiskas kompozicijas iegusanas panemiens bernu uztura iegusanas panemiens

Info

Publication number
LV10292A
LV10292A LV931005A LV931005A LV10292A LV 10292 A LV10292 A LV 10292A LV 931005 A LV931005 A LV 931005A LV 931005 A LV931005 A LV 931005A LV 10292 A LV10292 A LV 10292A
Authority
LV
Latvia
Prior art keywords
pharmaceutical composition
nutrition
bssl
protein
composition
Prior art date
Application number
LV931005A
Other languages
English (en)
Other versions
LV10292B (en
Inventor
Karl Gunnar Bjursell
Lars Gustav Blaeckberg
Peter Nils Ivar Carlsson
Curt Sven Magnus Enerbaeck
Carl Olof Edward Hernell
Jeanette Annika Nilsson
Thomas Olivercrona
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of LV10292A publication Critical patent/LV10292A/lv
Publication of LV10292B publication Critical patent/LV10292B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18Carboxylic ester hydrolases (3.1.1)
    • C12N9/20Triglyceride splitting, e.g. by means of lipase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • A61K8/375Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42Amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/442Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof substituted by amido group(s)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • A61K2800/596Mixtures of surface active compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
LVP-93-1005A 1990-06-01 1993-07-30 Derivatives of human bile salt stimulated lipase and pharmaceutical compositions containing them LV10292B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9001985A SE9001985D0 (sv) 1990-06-01 1990-06-01 New chemical products
PCT/SE1991/000381 WO1991018923A1 (en) 1990-06-01 1991-05-30 Derivatives of human bile-salt stimulated lipase, and pharmaceutical compositions containing them

Publications (2)

Publication Number Publication Date
LV10292A true LV10292A (lv) 1994-10-20
LV10292B LV10292B (en) 1995-08-20

Family

ID=20379662

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-93-1005A LV10292B (en) 1990-06-01 1993-07-30 Derivatives of human bile salt stimulated lipase and pharmaceutical compositions containing them

Country Status (44)

Country Link
EP (1) EP0535048B1 (lv)
JP (1) JPH05507201A (lv)
KR (1) KR100212411B1 (lv)
CN (2) CN1075113C (lv)
AP (1) AP207A (lv)
AT (1) ATE151077T1 (lv)
AU (1) AU651979B2 (lv)
BG (1) BG61165B1 (lv)
CA (1) CA2083396C (lv)
CZ (1) CZ287470B6 (lv)
DE (1) DE69125489T2 (lv)
DK (1) DK0535048T3 (lv)
DZ (1) DZ1503A1 (lv)
EG (1) EG19937A (lv)
ES (1) ES2099159T3 (lv)
FI (1) FI114639B (lv)
GR (1) GR3023618T3 (lv)
HK (1) HK62497A (lv)
HR (1) HRP920771B1 (lv)
HU (1) HU215258B (lv)
IE (1) IE911844A1 (lv)
IL (1) IL98273A (lv)
IS (1) IS1751B (lv)
JO (1) JO1694B1 (lv)
LT (1) LT4020B (lv)
LV (1) LV10292B (lv)
MA (1) MA22166A1 (lv)
MY (1) MY111245A (lv)
NO (1) NO322962B1 (lv)
NZ (1) NZ238223A (lv)
PH (1) PH30761A (lv)
PL (1) PL166534B1 (lv)
PT (1) PT97836B (lv)
RO (1) RO114793B1 (lv)
RU (1) RU2140983C1 (lv)
SE (1) SE9001985D0 (lv)
SG (1) SG48078A1 (lv)
SK (1) SK281089B6 (lv)
TN (1) TNSN91041A1 (lv)
TW (1) TW221712B (lv)
UA (1) UA39165C2 (lv)
WO (1) WO1991018923A1 (lv)
YU (1) YU49138B (lv)
ZA (1) ZA913778B (lv)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5616483A (en) * 1992-06-11 1997-04-01 Aktiebolaget Astra Genomic DNA sequences encoding human BSSL/CEL
IS4130A (is) * 1993-03-01 1994-09-02 Ab Astra Ný fjölpeptíð
SE9300686D0 (sv) 1993-03-01 1993-03-01 Astra Ab Novel polypeptides
FR2754827B1 (fr) * 1996-10-17 1998-12-24 Biocem Lipases pancreatiques et/ou colipases recombinantes et polypeptides dervies produits par les plantes, leurs procedes d'obtention et leurs utilisations
JP2000026311A (ja) * 1998-07-02 2000-01-25 Amano Pharmaceut Co Ltd 胃排出能亢進剤組成物
EP1963524A2 (en) * 2005-12-01 2008-09-03 University of Bergen Diagnosis and treatment of exocrine pancreatic dysfunction and diabetes using human cel gene
HUE033217T2 (hu) 2010-04-23 2017-11-28 Alexion Pharma Inc Lizoszomális tárolási betegséggel asszociált enzim
ME02062B (me) 2010-09-09 2015-05-20 Synageva Biopharma Corp Primena lizozomalne kisele lipaze za lecenje nedostatka lizozomalne kisele lipaze kod pacijenata
CA2812852A1 (en) 2010-10-21 2012-04-26 Swedish Orphan Biovitrum Ab (Publ) Method to increase the absorption of unsaturated fatty acids by human infants
CN103200957A (zh) 2010-10-21 2013-07-10 瑞典孤儿比奥维特鲁姆有限公司 提高人婴儿之生长速度的方法
CA3066521A1 (en) 2017-06-19 2018-12-27 Swedish Orphan Biovitrum Ab (Publ) Fusion protein with half-life extending polypeptide
EP4501403A3 (en) 2019-08-30 2025-05-14 Société des Produits Nestlé S.A. Engineered lipase variants

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60501758A (ja) * 1983-07-01 1985-10-17 セルテク リミテツド タンパク質、医薬構成物、遺伝子、ベクタ−宿主生物及びそれらの生産方法

Also Published As

Publication number Publication date
IL98273A (en) 2005-11-20
EP0535048B1 (en) 1997-04-02
RU2140983C1 (ru) 1999-11-10
NO924528D0 (no) 1992-11-24
AU7964591A (en) 1991-12-31
TW221712B (lv) 1994-03-11
HK62497A (en) 1997-05-16
PT97836B (pt) 1998-11-30
CA2083396A1 (en) 1991-12-02
PL166534B1 (pl) 1995-05-31
HUT63184A (en) 1993-07-28
FI925453A0 (fi) 1992-11-30
HU9203774D0 (en) 1993-03-29
IE911844A1 (en) 1991-12-04
DZ1503A1 (fr) 2004-09-13
AU651979B2 (en) 1994-08-11
BG61165B1 (bg) 1997-01-31
TNSN91041A1 (fr) 1992-10-25
PH30761A (en) 1997-10-17
DE69125489D1 (de) 1997-05-07
RO114793B1 (ro) 1999-07-30
CN1326782A (zh) 2001-12-19
JO1694B1 (en) 1992-08-09
YU49138B (sh) 2004-03-12
ATE151077T1 (de) 1997-04-15
NO924528L (no) 1992-11-24
EP0535048A1 (en) 1993-04-07
LV10292B (en) 1995-08-20
SE9001985D0 (sv) 1990-06-01
SG48078A1 (en) 1998-04-17
PT97836A (pt) 1992-02-28
JPH05507201A (ja) 1993-10-21
WO1991018923A1 (en) 1991-12-12
GR3023618T3 (en) 1997-08-29
HRP920771B1 (en) 1999-10-31
HRP920771A2 (en) 1997-04-30
IS3710A7 (is) 1991-12-02
UA39165C2 (uk) 2001-06-15
DK0535048T3 (da) 1997-09-29
AP207A (en) 1992-08-18
LT4020B (en) 1996-08-26
NZ238223A (en) 1993-05-26
MY111245A (en) 1999-10-30
CZ164491A3 (cs) 1999-07-14
SK164491A3 (en) 1995-07-11
CZ287470B6 (cs) 2000-12-13
MA22166A1 (fr) 1991-12-31
DE69125489T2 (de) 1997-08-14
FI114639B (fi) 2004-11-30
LTIP1736A (en) 1995-08-25
YU95191A (sh) 1994-06-10
FI925453L (fi) 1992-11-30
IL98273A0 (en) 1992-06-21
ES2099159T3 (es) 1997-05-16
SK281089B6 (sk) 2000-11-07
HU215258B (hu) 1998-11-30
CA2083396C (en) 2006-09-19
EG19937A (en) 2000-12-31
CN1075113C (zh) 2001-11-21
CN1064313A (zh) 1992-09-09
IS1751B (is) 2000-07-21
BG97123A (bg) 1993-12-24
KR100212411B1 (en) 1999-08-02
NO322962B1 (no) 2006-12-18
AP9100270A0 (en) 1991-07-31
ZA913778B (en) 1992-02-26

Similar Documents

Publication Publication Date Title
LV10292A (lv) Olbaltumvielas DNS vektori farmaceitiskas kompozicijas olbaltumvielu pielietojums kompozicija uzturam farmaceitiskas kompozicijas iegusanas panemiens bernu uztura iegusanas panemiens
WO1998014592A3 (en) Telomerase reverse transcriptase
AR017866A1 (es) Metodo para incrementar las inmunorespuestas de vacunas de acidos nucleicos, composiciones farmaceuticas de aplicacion en dicho metodo, procedimientopara preparar dichas composiciones y vacunas utilizadas en dicho metodo.
DK0802913T3 (da) Imidazo[4,5-c]quinolinaminer
DE3587958D1 (de) Rekombinantes alveolares oberflächenaktives protein.
NO883926D0 (no) Fremgangsmaate for fremstilling av stabilisert humanproteinpreparat.
CA2102693A1 (en) Protein formulation comprising growth hormone
GR3000350T3 (en) Hair cosmetics
DE60207234D1 (de) Verfahren zur herstellung einer gereinigten shilajit-zusammensetzung aus nativem shilajit
ES2114616T3 (es) Acidos dicarboxilicos alifaticos insaturados.
NO960309L (no) Agonister og antagonister for humaninterleukin-10
AU4282885A (en) Cosmetic preparation
NZ332565A (en) Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
GR3034309T3 (en) IFN--g(b) LIQUID FORMULATIONS
EP1591528A3 (en) Method and compositions for delivery and expression of interferon-alpha nucleic acids
EP0317279A3 (en) Peptides for use in the purification of factor viii
DK0550783T3 (da) Anvendelse af diolestere i hunde- og kattefoder
WO2001036458A3 (en) Drosophila ced-6 homologue
RU99114027A (ru) Нуклеиново-кислотные и аминокислотные последовательности helicobacter pylory и их вакцинные композиции